279 related articles for article (PubMed ID: 19855393)
1. Activating mutations in FGFR3 and HRAS reveal a shared genetic origin for congenital disorders and testicular tumors.
Goriely A; Hansen RM; Taylor IB; Olesen IA; Jacobsen GK; McGowan SJ; Pfeifer SP; McVean GA; Rajpert-De Meyts E; Wilkie AO
Nat Genet; 2009 Nov; 41(11):1247-52. PubMed ID: 19855393
[TBL] [Abstract][Full Text] [Related]
2. Exploring the Micro-Mosaic Landscape of
Striedner Y; Arbeithuber B; Moura S; Nowak E; Reinhardt R; Muresan L; Salazar R; Ebner T; Tiemann-Boege I
Genes (Basel); 2024 Jan; 15(2):. PubMed ID: 38397181
[TBL] [Abstract][Full Text] [Related]
3. Paternal age effect mutations and selfish spermatogonial selection: causes and consequences for human disease.
Goriely A; Wilkie AO
Am J Hum Genet; 2012 Feb; 90(2):175-200. PubMed ID: 22325359
[TBL] [Abstract][Full Text] [Related]
4. Contributions of intrinsic mutation rate and selfish selection to levels of de novo HRAS mutations in the paternal germline.
Giannoulatou E; McVean G; Taylor IB; McGowan SJ; Maher GJ; Iqbal Z; Pfeifer SP; Turner I; Burkitt Wright EM; Shorto J; Itani A; Turner K; Gregory L; Buck D; Rajpert-De Meyts E; Looijenga LH; Kerr B; Wilkie AO; Goriely A
Proc Natl Acad Sci U S A; 2013 Dec; 110(50):20152-7. PubMed ID: 24259709
[TBL] [Abstract][Full Text] [Related]
5. Whole-genome sequencing of spermatocytic tumors provides insights into the mutational processes operating in the male germline.
Giannoulatou E; Maher GJ; Ding Z; Gillis AJM; Dorssers LCJ; Hoischen A; Rajpert-De Meyts E; ; McVean G; Wilkie AOM; Looijenga LHJ; Goriely A
PLoS One; 2017; 12(5):e0178169. PubMed ID: 28542371
[TBL] [Abstract][Full Text] [Related]
6. Incidence of fibroblast growth factor receptor 3 gene (FGFR3) A248C, S249C, G372C, and T375C mutations in bladder cancer.
Dodurga Y; Tataroglu C; Kesen Z; Satiroglu-Tufan NL
Genet Mol Res; 2011 Jan; 10(1):86-95. PubMed ID: 21264819
[TBL] [Abstract][Full Text] [Related]
7. Presence of somatic mutations within PIK3CA, AKT, RAS, and FGFR3 but not BRAF in cisplatin-resistant germ cell tumors.
Feldman DR; Iyer G; Van Alstine L; Patil S; Al-Ahmadie H; Reuter VE; Bosl GJ; Chaganti RS; Solit DB
Clin Cancer Res; 2014 Jul; 20(14):3712-20. PubMed ID: 24812411
[TBL] [Abstract][Full Text] [Related]
8. Exome-wide Sequencing Shows Low Mutation Rates and Identifies Novel Mutated Genes in Seminomas.
Cutcutache I; Suzuki Y; Tan IB; Ramgopal S; Zhang S; Ramnarayanan K; Gan A; Lee HH; Tay ST; Ooi A; Ong CK; Bolthouse JT; Lane BR; Anema JG; Kahnoski RJ; Tan P; Teh BT; Rozen SG
Eur Urol; 2015 Jul; 68(1):77-83. PubMed ID: 25597018
[TBL] [Abstract][Full Text] [Related]
9. Novel fibroblast growth factor receptor 3 (FGFR3) mutations in bladder cancer previously identified in non-lethal skeletal disorders.
van Rhijn BW; van Tilborg AA; Lurkin I; Bonaventure J; de Vries A; Thiery JP; van der Kwast TH; Zwarthoff EC; Radvanyi F
Eur J Hum Genet; 2002 Dec; 10(12):819-24. PubMed ID: 12461689
[TBL] [Abstract][Full Text] [Related]
10. Mutations in FGFR3 and PIK3CA, singly or combined with RAS and AKT1, are associated with AKT but not with MAPK pathway activation in urothelial bladder cancer.
Juanpere N; Agell L; Lorenzo M; de Muga S; López-Vilaró L; Murillo R; Mojal S; Serrano S; Lorente JA; Lloreta J; Hernández S
Hum Pathol; 2012 Oct; 43(10):1573-82. PubMed ID: 22417847
[TBL] [Abstract][Full Text] [Related]
11. The mutational spectrum of HRAS, KRAS, NRAS and FGFR3 genes in bladder cancer.
Ouerhani S; Elgaaied AB
Cancer Biomark; 2011-2012; 10(6):259-66. PubMed ID: 22820081
[TBL] [Abstract][Full Text] [Related]
12. Expression of FGFR3 during human testis development and in germ cell-derived tumours of young adults.
Ewen KA; Olesen IA; Winge SB; Nielsen AR; Nielsen JE; Graem N; Juul A; Rajpert-De Meyts E
Int J Dev Biol; 2013; 57(2-4):141-51. PubMed ID: 23784824
[TBL] [Abstract][Full Text] [Related]
13. Cellular evidence for selfish spermatogonial selection in aged human testes.
Maher GJ; Goriely A; Wilkie AO
Andrology; 2014 May; 2(3):304-14. PubMed ID: 24357637
[TBL] [Abstract][Full Text] [Related]
14. Distinct missense mutations of the FGFR3 lys650 codon modulate receptor kinase activation and the severity of the skeletal dysplasia phenotype.
Bellus GA; Spector EB; Speiser PW; Weaver CA; Garber AT; Bryke CR; Israel J; Rosengren SS; Webster MK; Donoghue DJ; Francomano CA
Am J Hum Genet; 2000 Dec; 67(6):1411-21. PubMed ID: 11055896
[TBL] [Abstract][Full Text] [Related]
15. Novel insights into the mixed germ cell-sex cord stromal tumor of the testis: detection of chromosomal aneuploidy and further morphological evidence supporting the neoplastic nature of the germ cell component.
Michalova K; McKenney JK; Kristiansen G; Steiner P; Grossmann P; Putzova M; Martinek P; Chottova-Dvorakova M; Michal M; Hes O; Michal M
Virchows Arch; 2020 Nov; 477(5):615-623. PubMed ID: 32447491
[TBL] [Abstract][Full Text] [Related]
16. High frequency of FGFR3 mutations in adenoid seborrheic keratoses.
Hafner C; van Oers JM; Hartmann A; Landthaler M; Stoehr R; Blaszyk H; Hofstaedter F; Zwarthoff EC; Vogt T
J Invest Dermatol; 2006 Nov; 126(11):2404-7. PubMed ID: 16778799
[TBL] [Abstract][Full Text] [Related]
17. Selfish mutations dysregulating RAS-MAPK signaling are pervasive in aged human testes.
Maher GJ; Ralph HK; Ding Z; Koelling N; Mlcochova H; Giannoulatou E; Dhami P; Paul DS; Stricker SH; Beck S; McVean G; Wilkie AOM; Goriely A
Genome Res; 2018 Dec; 28(12):1779-1790. PubMed ID: 30355600
[TBL] [Abstract][Full Text] [Related]
18. The paradox of FGFR3 signaling in skeletal dysplasia: why chondrocytes growth arrest while other cells over proliferate.
Krejci P
Mutat Res Rev Mutat Res; 2014; 759():40-8. PubMed ID: 24295726
[TBL] [Abstract][Full Text] [Related]
19. TP53 codon 72 polymorphism is associated with FGFR3 and RAS mutation in non-muscle-invasive bladder cancer.
Kawahara T; Kojima T; Kandori S; Kurobe M; Yoshino T; Kimura T; Nagumo Y; Ishituka R; Mitsuzuka K; Narita S; Kobayashi T; Matsui Y; Ogawa O; Sugimoto M; Miyazaki J; Nishiyama H
PLoS One; 2019; 14(8):e0220173. PubMed ID: 31369573
[TBL] [Abstract][Full Text] [Related]
20. Keratinocytic epidermal nevi are associated with mosaic RAS mutations.
Hafner C; Toll A; Gantner S; Mauerer A; Lurkin I; Acquadro F; Fernández-Casado A; Zwarthoff EC; Dietmaier W; Baselga E; Parera E; Vicente A; Casanova A; Cigudosa J; Mentzel T; Pujol RM; Landthaler M; Real FX
J Med Genet; 2012 Apr; 49(4):249-53. PubMed ID: 22499344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
